<?xml version="1.0" encoding="UTF-8"?>
<ref id="B226-nutrients-13-00462">
 <label>226.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Miller</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ballantyne</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Bays</surname>
    <given-names>H.E.</given-names>
   </name>
   <name>
    <surname>Granowitz</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Doyle</surname>
    <given-names>R.T.</given-names>
   </name>
   <name>
    <surname>Juliano</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Philip</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Effects of icosapent ethyl (eicosapentaenoic acid ethyl ester) on atherogenic lipid/lipoprotein, apolipoprotein, and inflammatory parameters in patients with elevated high-sensitivity c-reactive protein (from the anchor study)</article-title>
  <source>Am. J. Cardiol.</source>
  <year>2019</year>
  <volume>124</volume>
  <fpage>696</fpage>
  <lpage>701</lpage>
  <pub-id pub-id-type="doi">10.1016/j.amjcard.2019.05.057</pub-id>
  <?supplied-pmid 31277790?>
  <pub-id pub-id-type="pmid">31277790</pub-id>
 </element-citation>
</ref>
